Nova In Vitro Fertilization

Mountain View, California 94040

Medical Director: Richard J. Schmidt, MD

Nova In Vitro Fertilization, located in Mountain View, California, offers comprehensive fertility care under the experienced guidance of Medical Director Richard J. Schmidt, MD. The clinic provides essential services including IVF, egg freezing, and surrogacy support, helping individuals and couples navigate their unique paths to parenthood. With a verified lab accreditation, Nova maintains the high standards of care that patients deserve during this important journey.

The clinic's track record reflects their commitment to successful outcomes, with live birth rates of 55% for patients under 35 and 54.5% for those ages 35-37. Having completed 533 treatment cycles in 2022, the team at Nova brings both expertise and personalized attention to each patient's care. Located in the heart of Silicon Valley, Nova In Vitro Fertilization combines medical excellence with a understanding that fertility treatment can feel overwhelming – their approach focuses on providing clarity and support throughout the process, helping you make informed decisions about your reproductive health and family-building goals.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Surrogacy

Gestational carrier arrangements — an embryo is transferred to a surrogate who carries the pregnancy.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3555.00%+6.648.90%48.4%
35–3754.50%+18.563.20%36%
38–4026.90%+3.342.40%23.6%
Over 4012.90%+3.4Not reported9.5%

Based on 533 total cycles reported. National averages computed across all reporting clinics.

Nearby Clinics

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.